The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

cross-posted from: https://lemm.ee/post/64477597

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • stangel@lemmy.worldEnglish
    5·
    1 month ago

    Correct me if i’m wrong, but don’t the terms of the sale require the buyer to honor 23 and me’s privacy policy?

  • Darkassassin07English
    3·
    1 month ago

    Breaking news; company does what’s it’s been advertising for half a decade. More at 11.